Randomized, Open-Label, 2-Period Cross-Over Study in Healthy Adults to Evaluate the Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir.
Phase of Trial: Phase I
Latest Information Update: 13 May 2016
At a glance
- Drugs Paritaprevir (Primary) ; Ritonavir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 13 May 2016 Results (n=4) assessing the Metabolism and Disposition in Paritaprevir, published in the Drug Metabolism and Disposition
- 07 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 07 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.